ENTRADA THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
ENTRADA THERAPEUTICS, INC. (TRDA) reported Increase (Decrease) in Other Noncurrent Assets of $48.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $28.00K.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $20.00K.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$93.00K.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$36.00K.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$214.00K.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$2.51M, a 121.67% decline from fiscal 2023.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $11.56M, a 166.55% increase from fiscal 2022.
- ENTRADA THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was $4.34M, a 1210.57% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $48.00K 10-Q · filed 2026-08-05 | -$45.00K derived: sum of 3 quarters · filed 2026-08-05 | -$81.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $20.00K 10-Q · filed 2026-05-07 | -$73.00K derived: sum of 2 quarters · filed 2026-05-07 | -$109.00K derived: sum of 3 quarters · filed 2026-05-07 | -$149.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$129.00K derived: sum of 2 quarters · filed 2026-02-26 | -$169.00K derived: sum of 3 quarters · filed 2026-08-05 | -$214.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$76.00K derived: sum of 2 quarters · filed 2026-08-05 | -$121.00K 10-Q · filed 2025-11-06 | -$583.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$85.00K 10-Q · filed 2026-08-05 | -$547.00K derived: sum of 3 quarters · filed 2026-08-05 | -$548.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$45.00K 10-Q · filed 2026-05-07 | -$507.00K derived: sum of 2 quarters · filed 2026-05-07 | -$508.00K derived: sum of 3 quarters · filed 2026-05-07 | -$2.52M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$463.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.48M derived: sum of 3 quarters · filed 2026-02-26 | -$2.51M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.02M derived: sum of 2 quarters · filed 2025-11-06 | -$2.04M 10-Q · filed 2025-11-06 | -$2.23M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.04M 10-Q · filed 2025-08-06 | -$2.23M derived: sum of 3 quarters · filed 2025-08-06 | $209.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$28.00K 10-Q · filed 2025-05-08 | -$219.00K derived: sum of 2 quarters · filed 2025-05-08 | $2.22M derived: sum of 3 quarters · filed 2025-05-08 | $2.90M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.25M derived: sum of 2 quarters · filed 2025-02-27 | $2.93M derived: sum of 3 quarters · filed 2025-02-27 | $11.56M 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.12M derived: sum of 2 quarters · filed 2024-11-05 | $11.75M 10-Q · filed 2024-11-05 | $16.01M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $9.31M 10-Q · filed 2024-08-13 | $13.57M derived: sum of 3 quarters · filed 2024-08-13 | $13.65M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $8.63M 10-Q · filed 2024-05-07 | $12.89M derived: sum of 2 quarters · filed 2024-05-07 | $12.97M derived: sum of 3 quarters · filed 2024-05-07 | $12.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.33M derived: sum of 2 quarters · filed 2024-03-13 | $3.78M derived: sum of 3 quarters · filed 2024-03-13 | $4.34M 10-K · filed 2024-03-13 |
| 2022-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$480.00K derived: sum of 2 quarters · filed 2023-11-07 | $82.00K 10-Q · filed 2023-11-07 | -$1.51M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$559.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.00K 10-Q · filed 2023-08-08 | -$1.59M derived: sum of 3 quarters · filed 2023-08-08 | $348.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $562.00K 10-Q · filed 2023-05-10 | -$1.03M derived: sum of 2 quarters · filed 2023-05-10 | $907.00K derived: sum of 3 quarters · filed 2023-05-10 | $916.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $345.00K derived: sum of 2 quarters · filed 2023-03-06 | $354.00K derived: sum of 3 quarters · filed 2023-03-06 | $331.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.95M derived: sum of 2 quarters · filed 2022-11-07 | $1.92M 10-Q · filed 2022-11-07 | $1.92M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$14.00K 10-Q · filed 2022-08-11 | -$17.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$23.00K 10-Q · filed 2022-05-12 | -$26.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $541.00K 10-K · filed 2022-03-15 | ||
| 2020-09-30 | $544.00K 10-Q · filed 2021-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |